共 50 条
- [46] Natalizumab promotes activation and pro-inflammatory differentiation of peripheral B cells in multiple sclerosis patients Journal of Neuroinflammation, 16
- [48] The BCR-ABL1 kinase bypasses selection for the expression of a pre-B cell receptor in pre-B acute lymphoblastic leukemia cells JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (05): : 673 - 685
- [50] CD49d blockade by natalizumab therapy in patients with multiple sclerosis increases immature B-lymphocytes Bone Marrow Transplantation, 2011, 46 : 1489 - 1491